Evelo Biosciences, Inc. (EVLO)

Evelo Biosciences Analyst Ratings

EVLO's stock price has decreased by -98.28% in the past year and price targets may not have had time to catch up.

• Total Analysts: 2
• Consensus Rating: Hold
• Price Target: $10.00
• Upside: +22,888.51%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Thome TD Cowen	TD Cowen	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Oct 18, 2023
Vikram Purohit Morgan Stanley	Morgan Stanley	Hold Maintains $2 → $10	Hold	Maintains	$2 → $10	+22,888.51%	Jul 26, 2023
Vikram Purohit Morgan Stanley	Morgan Stanley	Hold Maintains $80 → $40	Hold	Maintains	$80 → $40	+91,854.02%	Feb 15, 2023
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy → Hold Downgrades $50	Strong Buy → Hold	Downgrades	$50	+114,842.53%	Nov 16, 2022
Vikram Purohit Morgan Stanley	Morgan Stanley	Hold Maintains $100 → $80	Hold	Maintains	$100 → $80	+183,808.05%	Sep 9, 2022
Vikram Purohit Morgan Stanley	Morgan Stanley	Hold Maintains $120 → $100	Hold	Maintains	$120 → $100	+229,785.06%	Aug 24, 2022
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy Maintains $240 → $100	Strong Buy	Maintains	$240 → $100	+229,785.06%	Aug 15, 2022
Gobind Singh JMP Securities	JMP Securities	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Nov 2, 2021
Keay Nakae Chardan Capital	Chardan Capital	Hold → Strong Buy Upgrades n/a	Hold → Strong Buy	Upgrades	n/a	n/a	Nov 1, 2021
Gobind Singh JMP Securities	JMP Securities	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Jun 23, 2021
Kristen Kluska Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Jun 23, 2021
Chris Howerton Jefferies	Jefferies	Hold → Strong Buy Upgrades n/a	Hold → Strong Buy	Upgrades	n/a	n/a	Apr 12, 2021
Matthew Harrison Morgan Stanley	Morgan Stanley	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	May 21, 2020
Chris Howerton Jefferies	Jefferies	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	May 12, 2020